A systematic literature review of disease burden and clinical efficacy for patients with relapsed or refractory acute myeloid leukemia.
A systematic literature review of disease burden and clinical efficacy for patients with relapsed or refractory acute myeloid leukemia. is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A systematic literature review of disease burden and clinical efficacy for patients with relapsed or refractory acute myeloid leukemia. have?
A systematic literature review of disease burden and clinical efficacy for patients with relapsed or refractory acute myeloid leukemia. has 10 citations in the OpenAlex counts ScholarIQ stores.
When was A systematic literature review of disease burden and clinical efficacy for patients with relapsed or refractory acute myeloid leukemia. published?
A systematic literature review of disease burden and clinical efficacy for patients with relapsed or refractory acute myeloid leukemia. has 2021 year in the ScholarIQ index.
What is the open-access status of A systematic literature review of disease burden and clinical efficacy for patients with relapsed or refractory acute myeloid leukemia.?
A systematic literature review of disease burden and clinical efficacy for patients with relapsed or refractory acute myeloid leukemia. has green oa status in the ScholarIQ index.
What is the PMID of A systematic literature review of disease burden and clinical efficacy for patients with relapsed or refractory acute myeloid leukemia.?
The PMID for A systematic literature review of disease burden and clinical efficacy for patients with relapsed or refractory acute myeloid leukemia. is on the source record.
What is the OpenAlex record for A systematic literature review of disease burden and clinical efficacy for patients with relapsed or refractory acute myeloid leukemia.?
The OpenAlex for A systematic literature review of disease burden and clinical efficacy for patients with relapsed or refractory acute myeloid leukemia. is on the source record.